Skip to main content
OPTIBIOTIX HEALTH PLC logo

OPTIBIOTIX HEALTH PLC — Investor Relations & Filings

Ticker · OPTI ISIN · GB00BP0RTP38 LEI · 213800UKYQFT941QHS14 IL Manufacturing
Open in API
Filings indexed 477 across all filing types
Latest filing 2025-08-21 Delisting Announcement
Country GB United Kingdom
Listing IL OPTI

About OPTIBIOTIX HEALTH PLC

https://www.optibiotix.com/

OptiBiotix Health PLC is a life sciences company specializing in the research and development of technologies that modulate the human microbiome. The company identifies and develops microbial strains, compounds, and formulations for use as food ingredients, dietary supplements, and active compounds. Its primary focus is on the prevention and management of chronic lifestyle diseases, including obesity, cardiovascular health issues such as high cholesterol, and diabetes. OptiBiotix's approach is founded on strong scientific evidence, with its product pipeline supported by clinical human studies. The company provides these clinically proven ingredients and white-label solutions to partners in the food, health, and wellness sectors.

Recent filings

Filing Released Lang Actions
Admission to Trading on the OTCQB Venture Market
Delisting Announcement Classification · 100% confidence The document is an official announcement from OptiBiotix Health PLC regarding the admission of its shares to trade on the OTCQB Venture Market in the United States. It is distributed via the London Stock Exchange's Regulatory News Service (RNS). Since it is a general corporate announcement regarding market access and does not fit into specific categories like M&A, share issuance, or financial reporting, it is classified as a Regulatory Filing (RNS).
2025-08-21 English
Agreement with Weight Management Company
Regulatory Filings Classification · 100% confidence The document is a press release distributed via the Regulatory News Service (RNS) of the London Stock Exchange. It announces a new commercial distribution agreement between OptiBiotix Health plc and a weight management company. Since this is a general corporate announcement regarding business operations and does not fit into specific categories like M&A (which usually involves ownership changes or takeovers), financial reports, or governance, it falls under the 'Regulatory Filings' (RNS) category as a general corporate update.
2025-08-20 English
Launch of SlimBiome in leading US brand
Regulatory Filings Classification · 100% confidence The document is a press release distributed via the London Stock Exchange's RNS (Regulatory News Service). It announces a commercial update regarding the launch of a product ('SlimBiome') in partnership with a US brand ('Hydroxycut'). As this is a general corporate announcement regarding business operations and product launches that does not fit into specific categories like financial reports, dividends, or board changes, it is classified as a Regulatory Filing (RNS).
2025-08-14 English
Result of AGM
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement from OptiBiotix Health plc regarding the 'Result of AGM'. It explicitly details the outcome of shareholder resolutions (1-4 passed, 5 failed) during the Annual General Meeting. This falls directly under the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA).
2025-08-06 English
Issue of Options
Share Issue/Capital Change Classification · 99% confidence The document is an RNS announcement from OptiBiotix Health PLC regarding the issuance of share options to a Director (Sofia Kolyda). It includes the mandatory 'Notification of a Transaction' table required under Article 19(1) of the UK Market Abuse Regulation for persons discharging managerial responsibilities (PDMR). While it involves a director, it specifically details the grant of options (a transaction in financial instruments) rather than a simple change in board composition or a personal trade of existing shares on the open market. Given the specific nature of the transaction (issue of options to a director), it falls under the category of Director's Dealing (DIRS).
2025-08-06 English
Trading update
Earnings Release Classification · 100% confidence The document is an 'Earnings Release' (ER) issued by OptiBiotix Health plc. It provides a trading update for the six months ended 30 June 2025, detailing key financial highlights such as gross revenue, gross profit, and operational updates. While it is distributed via RNS (a regulatory news service), the content itself is the primary announcement of financial results, not merely a notification of a report's availability. Therefore, it fits the definition of an Earnings Release. H1 2025
2025-07-28 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.